The U.S. Food and Drug Administration is on the brink of approving a breakthrough drug that could upend the way severe depression is treated.
Read MoreJanssen’s potential depression treatment made from esketamine – a version of the substance notoriously used illegally as a party drug – is to be reviewed by advisers to the FDA at a crunch meeting this week.
Read More